Page last updated: 2024-08-24

3-iodobenzylguanidine and Granuloma

3-iodobenzylguanidine has been researched along with Granuloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoefnagel, CA	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Granuloma

Article	Year
MIBG and radiolabeled octreotide in neuroendocrine tumors. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1 Topics: 3-Iodobenzylguanidine; Autoimmune Diseases; Cell Membrane; Cytoplasmic Granules; Forecasting; Granuloma; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Neuroendocrine Tumors; Octreotide; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Cell Surface; Receptors, Somatostatin; Somatostatin; Treatment Outcome	1995

Article

Year

MIBG and radiolabeled octreotide in neuroendocrine tumors.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

Topics: 3-Iodobenzylguanidine; Autoimmune Diseases; Cell Membrane; Cytoplasmic Granules; Forecasting; Granuloma; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Neuroendocrine Tumors; Octreotide; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Cell Surface; Receptors, Somatostatin; Somatostatin; Treatment Outcome

1995